UY29779A1 - Nitrooxi derivados de esteroides - Google Patents

Nitrooxi derivados de esteroides

Info

Publication number
UY29779A1
UY29779A1 UY29779A UY29779A UY29779A1 UY 29779 A1 UY29779 A1 UY 29779A1 UY 29779 A UY29779 A UY 29779A UY 29779 A UY29779 A UY 29779A UY 29779 A1 UY29779 A1 UY 29779A1
Authority
UY
Uruguay
Prior art keywords
nitrooxi
steroids
derived
nitrooxy
new
Prior art date
Application number
UY29779A
Other languages
English (en)
Spanish (es)
Inventor
Francesca Benedini
Ennio Onigini
Daniel Palop
Marta Princep
Original Assignee
Ferrer Int
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37450883&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY29779(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Int, Nicox Sa filed Critical Ferrer Int
Publication of UY29779A1 publication Critical patent/UY29779A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
UY29779A 2005-09-02 2006-09-01 Nitrooxi derivados de esteroides UY29779A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05019155 2005-09-02

Publications (1)

Publication Number Publication Date
UY29779A1 true UY29779A1 (es) 2006-12-29

Family

ID=37450883

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29779A UY29779A1 (es) 2005-09-02 2006-09-01 Nitrooxi derivados de esteroides

Country Status (19)

Country Link
US (5) US20080221073A1 (enExample)
EP (1) EP1940863B1 (enExample)
JP (1) JP5216589B2 (enExample)
KR (1) KR20080039442A (enExample)
CN (2) CN102134269A (enExample)
AR (1) AR056868A1 (enExample)
AU (1) AU2006286838C1 (enExample)
BR (1) BRPI0614967A2 (enExample)
CA (1) CA2621117A1 (enExample)
ES (1) ES2393363T3 (enExample)
IL (2) IL189337A0 (enExample)
NO (1) NO20081614L (enExample)
NZ (1) NZ566128A (enExample)
RU (1) RU2415864C2 (enExample)
SG (1) SG158916A1 (enExample)
TW (1) TW200801031A (enExample)
UY (1) UY29779A1 (enExample)
WO (1) WO2007025632A2 (enExample)
ZA (1) ZA200801789B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8802726B2 (en) 2006-02-03 2014-08-12 Nicox S.A. Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
US20100234334A1 (en) * 2007-02-05 2010-09-16 Nicox S.A. Nitric oxide releasing steroids
EP1964550A1 (en) * 2007-03-01 2008-09-03 NicOx S.A. Glucocorticoid-nitrooxyderivative compositions
ES2324007A1 (es) * 2007-10-25 2009-07-28 Ferrer Internacional, S.A. Una forma amorfa de un compuesto antiinflamatorio.
AU2009277381B2 (en) * 2008-07-31 2014-04-24 Nicox S.A. Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology
WO2010015528A1 (en) 2008-08-05 2010-02-11 Nicox S.A. New no-releasing steroids for the treatment of retina and macula lutea diseases
CN102186874A (zh) * 2008-08-05 2011-09-14 尼科克斯公司 新的释放no的类固醇衍生物
US8062653B2 (en) * 2009-02-18 2011-11-22 Bezwada Biomedical, Llc Controlled release of nitric oxide and drugs from functionalized macromers and oligomers
WO2010096320A2 (en) * 2009-02-18 2010-08-26 Bezwada Biomedical, Llc Controlled release of nitric oxide and drugs from functionalized macromers and oligomers
US9022788B2 (en) * 2009-10-17 2015-05-05 Gregory John Stahler System and method for cardiac defibrillation response simulation in health training mannequin
ES2359708B1 (es) 2009-11-16 2012-03-30 Ferrer Internacional S.A. Procedimiento de preparación de la (11beta,16alfa)-9-fluoro-11-hidroxi-16,17-[1-metil-etilidenebis(oxi)]-21-[1-oxo-[4-(nitrooximetil)benzoxi]]preña-1,4-dien-3,20-diona.
ES2362894B1 (es) 2009-11-16 2012-05-21 Ferrer Internacional S.A. Procedimiento de preparación del �?cido 4-nitro-oxi-metil-benzoico.
EP3525870B1 (en) * 2016-10-14 2023-05-10 Van Andel Research Institute Highly potent glucocorticoids
WO2021195126A1 (en) 2020-03-24 2021-09-30 Burnet Michael W Anti-infective and anti-viral compounds and compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE887518A (fr) 1980-02-15 1981-08-13 Glaxo Group Ltd Cartothioates d'androstanes
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
US5985862A (en) * 1996-05-02 1999-11-16 G.D. Searle & Co. Pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
US5837698A (en) * 1996-05-02 1998-11-17 G. D. Searle & Co. Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
IT1285770B1 (it) 1996-10-04 1998-06-18 Nicox Sa Composti corticoidei
IT1311922B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
ITMI20020148A1 (it) * 2002-01-29 2003-07-29 Nicox Sa Nuovi corticosteroidi
EP1336602A1 (en) * 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases

Also Published As

Publication number Publication date
IL189337A0 (en) 2008-06-05
NO20081614L (no) 2008-05-28
TW200801031A (en) 2008-01-01
AU2006286838B2 (en) 2012-03-29
ZA200801789B (en) 2008-12-31
RU2008111076A (ru) 2009-10-10
BRPI0614967A2 (pt) 2013-01-01
EP1940863A2 (en) 2008-07-09
KR20080039442A (ko) 2008-05-07
US20110294769A1 (en) 2011-12-01
IL216516A0 (en) 2011-12-29
US20080221073A1 (en) 2008-09-11
US20090264393A1 (en) 2009-10-22
JP5216589B2 (ja) 2013-06-19
RU2415864C2 (ru) 2011-04-10
NZ566128A (en) 2011-03-31
AU2006286838C1 (en) 2013-05-02
CN102134269A (zh) 2011-07-27
CN101300265A (zh) 2008-11-05
ES2393363T3 (es) 2012-12-20
WO2007025632A2 (en) 2007-03-08
SG158916A1 (en) 2010-02-26
US20090264394A1 (en) 2009-10-22
WO2007025632A3 (en) 2007-04-19
AR056868A1 (es) 2007-10-31
EP1940863B1 (en) 2012-09-05
JP2009506994A (ja) 2009-02-19
AU2006286838A1 (en) 2007-03-08
US20090258849A1 (en) 2009-10-15
CA2621117A1 (en) 2007-03-08

Similar Documents

Publication Publication Date Title
UY29779A1 (es) Nitrooxi derivados de esteroides
NO20075660L (no) Blanding for behandling av inflammatoriske sykdommer
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
DE50312034D1 (de) Liposomale glucocorticoide
CO5140098A1 (es) Combinaciones de un agonista de betra-2 y un esteroide, su uso para tratamiento de enfermedades inflamatorias u obstructivas de las vias aereas
NO20076508L (no) Acyloksykarbamat prodroger av traneksaminsyre og fremgangsmater for fremstilling og anvendelse derav
CY1115991T1 (el) Φαρμακευτικη ψεκαζομενη συνθεση που περιλαμβανει ενα αναλογο της βιταμινης d προϊον και ενα κορτικοστεροειδες
CO6430467A2 (es) Péptidos útiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosméticas o farmacéuticas
CL2007002791A1 (es) Compuestos derivados de sulfonamida; composicion farmaceutica que comprende a estos compuestos; combinacion farmaceutica que comprende a estos compuestos; y su uso para tratar trastornos, enfermedades y afecciones seleccionadas de asma, broncoconstri
CL2007002169A1 (es) Compuestos derivados de n-(amino-heteroaril)-1h-indol-2-carboxamidas; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y uso del compuesto para prevenir o tratar la inflamacion, trastornos urologicos, gastrointestina
BRPI0618239A8 (pt) uso de flibanserina para o tratamento de distúrbios de desejo sexual pré-menopáusicos
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
BRPI0517227B8 (pt) comprimido oral de liberação prolongada do ácido 1-{[alfa-isobutanoiloxietoxi)carbonil]amino metil}-1-cicloexano acético, e, uso do comprimido
UY29238A1 (es) Formulaciones de nepafenac para su administracion topica
CR6824A (es) Derivados de arilmetilamina para uso como inhibidores de triptasa
CL2011003144A1 (es) Forma cristalina e3 de bisulfato de atazanavir; composicion farmaceutica que la comprende; util para el tratamiento de enfermedades originadas por retrovirus (divisional de la solicitud 1057-05).
EA200301022A1 (ru) Гормональная заместительная терапия
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
SG152257A1 (en) Topical preparation containing ambroxol
ITVA20060041A1 (it) Uso di composti derivati amminotiazolici, di loro composizioni farmaceutiche, nel trattamento di malattie caratterizzate dalla anormale repressione della trascrizione genica, particolarmente il morbo di huntington
DK1487859T3 (da) Fremstillingsmetoder til at fremstille Eplerenon
ATE505477T1 (de) Amorphe form von (11beta,16alpha)-9-fluoro-11-
EP1594435A4 (en) INHIBITION OF HIV-1 REPLICATION BY TREATMENT OF THE PROCESSING OF THE VIRAL CAPSID-SPACER PEPTIDE 1 PROTEIN
ECSP003747A (es) Metodo y composiciones para el tratamiento de las enfermedades pulmonares
HUP0402624A2 (hu) Vírusgátlás n-dokozanollal